01 July 1999
Effect of treatment with methylprednisolone upon concentration of soluble form of IL-2R alpha and soluble forms of adhesive molecules : ICAM-1 and VCAM-1 in serum of patients with multiple sclerosisMałgorzata Bilińska, Irena Frydecka, Ryszard Podemski
Med Sci Monit 1999; 5(4): CR692-696 :: ID: 503491
The bout of multiple sclerosis implies activation of autoreactive mononuclear cells of peripheral blood and increased expression of adhesive cells on cerebral vessel endothelium. This results in the migration of cells and consequently, in the formation of perivascular infiltrations consisting of lymphocytes and macrophages, as well as the destruction of myelin in the brain and spinal cord. Steroid-therapy reduces clinical symptoms of MS bout, while nuclear magnetic resonance reveals the decrease of demyelinization foci after treatment. The aim of the present work was to evaluate the effect of methylprednisolone therapy upon the activation of immune system and clinical status estimated on EDSS scale. In our study, concentrations of sIL-2R alpha, sICAM-1 and sVCAM-1 were investigated in blood serum with the use of ELISA immunoenzyme assay. The study was performed in the group of 15 patients with the first bout of multiple sclerosis, who received intravenous infusion of methylprednisolone (1g) daily for 5 consecutive days. Neurological examinations as well as the determination of serum levels of cellular differentiation antigens listed above were performed before the start of therapy and 4 weeks after its completion. Control group was formed of 20 healthy persons. In patients with the first bout of the disease, mean serum concentrations of sIL-2R, sICAM-1 and sVCAM-1 were significantly higher when compared with the results obtained in control group. 4 weeks after therapy with methylprednisolone, a considerable improvement of neurological status was observed in patients from the study group. At that time, return to normal serum levels of mean sVCAM-1 concentration and a considerable decrease of mean sICAM-1 concentration were observed, while mean level of sIL-2R alpha did not change in a significant way. The improvement on EDDS scale after treatment correlated with the decrease of sICAM-1 in blood serum. The results of our study suggest that a beneficial clinical effect of steroid therapy in patients with multiple sclerosis may partly result from its inhibiting influence on the expression of adhesive cells, which consequently may lead to reduced migration of activated cells of immune system to central nervous system.
Keywords: Immune System, steroid therapy, Multiple Sclerosis
01 February 2024 : EditorialEditorial: Global Health Concerns as Vaccine-Preventable Infections Including SARS-CoV-2 (JN.1), Influenza, Respiratory Syncytial Virus (RSV), and Measles Continue to Rise
Med Sci Monit 2024; 30:e943911
05 Jan 2024 : Clinical ResearchEffectiveness of Glutamine Oral Care in Reducing Oral Mucositis and Improving Oral Health After Neurosurger...
Med Sci Monit In Press; DOI: 10.12659/MSM.942585
02 Jan 2024 : Clinical ResearchUrinary Concentration of Renal Biomarkers in Healthy Term Neonates: Gender Differences in GST-pi Excretion
Med Sci Monit In Press; DOI: 10.12659/MSM.942819
29 Dec 2023 : Clinical ResearchPerformance of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) in Chinese Population with Prima...
Med Sci Monit In Press; DOI: 10.12659/MSM.942747
Most Viewed Current Articles
16 May 2023 : Clinical ResearchElectrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review articleVaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical ResearchPrevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels
Med Sci Monit 2022; 28:e937990